Cargando…
Nonpharmaceutical interventions for managing SARS-CoV-2
Initial response strategies to the COVID-19 pandemic were heavily reliant on nonpharmaceutical interventions (NPIs), a set of measures implemented to slow or even stop the spread of infection. Here, we reviewed key measures used during the COVID-19 pandemic. RECENT FINDINGS: Some NPIs were successfu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090342/ https://www.ncbi.nlm.nih.gov/pubmed/36856551 http://dx.doi.org/10.1097/MCP.0000000000000949 |
_version_ | 1785022941062234112 |
---|---|
author | Murphy, Caitriona Wong, Jessica Y. Cowling, Benjamin J. |
author_facet | Murphy, Caitriona Wong, Jessica Y. Cowling, Benjamin J. |
author_sort | Murphy, Caitriona |
collection | PubMed |
description | Initial response strategies to the COVID-19 pandemic were heavily reliant on nonpharmaceutical interventions (NPIs), a set of measures implemented to slow or even stop the spread of infection. Here, we reviewed key measures used during the COVID-19 pandemic. RECENT FINDINGS: Some NPIs were successful in reducing the transmission of SARS-CoV-2. Personal protective measures such as face masks were widely used, and likely had some effect on transmission. The development and production of rapid antigen tests allowed self-diagnosis in the community, informing isolation and quarantine measures. Community-wide measures such as school closures, workplace closures and complete stay-at-home orders were able to reduce contacts and prevent transmission. They were widely used in the pandemic and contributed to reduce transmission in the community; however, there were also negative unintended consequences in the society and economy. SUMMARY: NPIs slowed the spread of SARS-CoV-2 and are essential for pandemic preparedness and response. Understanding which measures are more effective at reducing transmission with lower costs is imperative. |
format | Online Article Text |
id | pubmed-10090342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-100903422023-04-13 Nonpharmaceutical interventions for managing SARS-CoV-2 Murphy, Caitriona Wong, Jessica Y. Cowling, Benjamin J. Curr Opin Pulm Med INFECTIOUS DISEASES: Edited by Alimuddin Zumla and David SC Hui Initial response strategies to the COVID-19 pandemic were heavily reliant on nonpharmaceutical interventions (NPIs), a set of measures implemented to slow or even stop the spread of infection. Here, we reviewed key measures used during the COVID-19 pandemic. RECENT FINDINGS: Some NPIs were successful in reducing the transmission of SARS-CoV-2. Personal protective measures such as face masks were widely used, and likely had some effect on transmission. The development and production of rapid antigen tests allowed self-diagnosis in the community, informing isolation and quarantine measures. Community-wide measures such as school closures, workplace closures and complete stay-at-home orders were able to reduce contacts and prevent transmission. They were widely used in the pandemic and contributed to reduce transmission in the community; however, there were also negative unintended consequences in the society and economy. SUMMARY: NPIs slowed the spread of SARS-CoV-2 and are essential for pandemic preparedness and response. Understanding which measures are more effective at reducing transmission with lower costs is imperative. Lippincott Williams & Wilkins 2023-05 2023-03-01 /pmc/articles/PMC10090342/ /pubmed/36856551 http://dx.doi.org/10.1097/MCP.0000000000000949 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | INFECTIOUS DISEASES: Edited by Alimuddin Zumla and David SC Hui Murphy, Caitriona Wong, Jessica Y. Cowling, Benjamin J. Nonpharmaceutical interventions for managing SARS-CoV-2 |
title | Nonpharmaceutical interventions for managing SARS-CoV-2 |
title_full | Nonpharmaceutical interventions for managing SARS-CoV-2 |
title_fullStr | Nonpharmaceutical interventions for managing SARS-CoV-2 |
title_full_unstemmed | Nonpharmaceutical interventions for managing SARS-CoV-2 |
title_short | Nonpharmaceutical interventions for managing SARS-CoV-2 |
title_sort | nonpharmaceutical interventions for managing sars-cov-2 |
topic | INFECTIOUS DISEASES: Edited by Alimuddin Zumla and David SC Hui |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090342/ https://www.ncbi.nlm.nih.gov/pubmed/36856551 http://dx.doi.org/10.1097/MCP.0000000000000949 |
work_keys_str_mv | AT murphycaitriona nonpharmaceuticalinterventionsformanagingsarscov2 AT wongjessicay nonpharmaceuticalinterventionsformanagingsarscov2 AT cowlingbenjaminj nonpharmaceuticalinterventionsformanagingsarscov2 |